By the end of the year and up to, In joint statement, New York-based Pfizer Inc and Mainz-based company BioNTech SE expect to be able to produce million doses1.3 billion doses next year. ..…

The action comes days after Pfizer Inc and its German BioNTech announced that its vaccine appears 95% effective at preventing mild to COVID-19 in large, ongoing study.. ... U.S government has contract to buy millions of Pfizer- BioNTech doses, and has promised shots will be free.. ..…

The British on Friday has asked its independent medicines regulator to study Pfizer BioNTech's coronavirus vaccine with view to imminent roll-out.. ... Health Secretary Matt Hancock said the government had asked the Medicines and Healthcare products Regulatory Agency to assess Pfizer..…

Professor Ugur Sahin, chief of Germany's BioNTech, was absolutely essential to have vaccination rate before next autumn to ensure return to life next winter... ... Pfizer and BioNTech said last week that interim results showed the vaccine was 90% in preventing people from getting ill..…

Ugur Sahin and Ozlem Tureci are the co-founders of BioNTech SE, German company that, appears closest to rolling out vaccine against Covid-19. ... Sahin and Tureci are now, thanks to BioNTech's soaring share price, among Germans, at least on paper. ..…

Upcoming events on BIONTECH SE.. 10 20  . Society of immunotherapy of cancer meeting - abstract number 391 11 20   03 00pm  . Past events on BIONTECH SE.. 08 11 20   02 00pm  . Erstes Halbjahr 2020 Präsentation des Ergebnisses 08 11 20   12 03pm  . ..…

The new site, with its 300 staff that will join BioNTech, will allow for larger 2021 output target and it's not yet clear by how much on balance, .. The biotech firm said the facility will be one of mRNA manufacturing sites Europe, alongside two of BioNTech's existing production sites. ..…

BioNTech has established broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, member of Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.. ... For discussion of these and other risks and uncertainties,..…

Pfizer and its German, BioNTech, could have as many as 1.3 billion doses of their BNT162b2 coronavirus vaccine ready by the end of 2021.. thestreet.com%2Finvesting%2Fpfizer-and-biontech-reach-coronavirus-vaccine-deal-with-eu, 'socialSharefacebook, 'width=500, height=500, 'noopener )..…

The CanSino vaccine is not mRNA vaccine, like the development from Moderna and Pfizer and BioNTech. ... Early data so far suggest that Pfizer BioNTech candidate elicits T cell responses than Moderna's, the analysts wrote. ..…

Why Moderna, Vaxart, Inovio, and BioNTech Stocks Dropped Today. Author Bio Joe honed his investing skills Supernova, and Fool One. ... By the close of trading, shares of Vaxart, Inovio Pharmaceuticals, BioNTech, and Moderna were down 11.3%, 10.9%, 2.8%, and 4.9%, respectively.. ..…

Pfizer and BioNTech, ments that American people would receive the future vaccine for free in line with Trump administration's pledge.. ... BioNTech spokeswoman told AFP that two injections would be needed for protection, with the booster shot following seven days after the first..…

Video Transcript Pfizer and its German, BioNTech, secured nearly $2 order from U.S for vaccine that does not yet exist.. ... Pfizer's and BioNTech's vaccine has shown promise small, early-stage studies in humans. ..…

The US government has signed billion deal to secure access to 100 million doses of Covid vaccine being developed by German company BioNTech with Pfizer.. The deal, announced by BioNTech is part of US programme Operation Warp Speed to deliver 300 million doses on Covid by the end of next..…